
Giannis Mountzios/LinkedIn
May 19, 2025, 10:12
Giannis Mountzios: Join Upcoming Discussion on DLL3 T-Cell Engagers in SCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, posted on X:
“Following the presentation of the landmark DeLLphi-304 trial on Tarlatamab vs SoC Chemotherapy in patients with pre-treated SCLC in ASCO25.
Join Dr Jacob Sands and me on June 17th in a hands-on, comprehensive read-out discussion on DLL-3 T-cell engagers and SCLC hosted by 1 and only Solange Peters.”
More posts featuring Giannis Mountzios.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 19, 2025, 10:12
May 19, 2025, 10:02
May 19, 2025, 10:00
May 19, 2025, 09:45
May 19, 2025, 09:44
May 19, 2025, 09:32
May 19, 2025, 09:29